{"id":409984,"date":"2021-01-06T17:32:24","date_gmt":"2021-01-06T22:32:24","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=409984"},"modified":"2021-01-06T17:32:24","modified_gmt":"2021-01-06T22:32:24","slug":"supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\/","title":{"rendered":"Supernus to Present at J.P. Morgan 39th Annual Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">ROCKVILLE, Md., Jan.  06, 2021  (GLOBE NEWSWIRE) &#8212; Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company&#8217;s management will present at the J.P. Morgan 39<sup>th<\/sup> Annual Healthcare Conference on Thursday, January 14, 2021, at 9:10 a.m. ET, and will be available for virtual investor meetings.<\/p>\n<p>A live webcast of the presentation can be accessed by visiting <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=k1HbYB8JBquJI69yP4OpKtdNbEwGjjh_K80-oSgI6cMKWmV5yypLmvogG7zuJmhJ9SOSLJFcNCiqCr2UaUCUlAzmCWjlhmjrOpzCm7ZyOuDvvaaID-fj5rgWdb4fCGBl\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Events &amp; Presentations<\/a> in the Investor Relations section on the Company&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8hDVVEGs8N4FgGvmebLXuxR1ySBdcBWSXy3hZ6zPFsmDTySh2IG8HmgdYEMETGPspGvlEkiGG-nw-qjmBjRvDQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.supernus.com<\/a>. An archived replay of this webcast will be available for 60 days on the Company&#8217;s website after the conference.<\/p>\n<p>\n        <strong>About Supernus Pharmaceuticals,\u00a0Inc.<\/strong>\n      <\/p>\n<p>Supernus Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. The Company markets Trokendi XR\u00ae (extended-release topiramate) for the prophylaxis of migraine and the treatment of epilepsy; Oxtellar XR\u00ae (extended-release oxcarbazepine) for the treatment of epilepsy; APOKYN\u00ae (apomorphine hydrochloride injection) for the acute treatment of hypomobility in advanced Parkinson\u2019s disease (PD); MYOBLOC\u00ae (rimabotulinumtoxinB) for the treatment of cervical dystonia and treatment of chronic sialorrhea in adults; and XADAGO\u00ae (safinamide) as an adjunctive treatment to levodopa\/carbidopa in PD patients with hypomobility. The Company is also developing several product candidates to address large market opportunities in the CNS market, including SPN-812 for the treatment of ADHD; SPN-830 (apomorphine infusion pump) for the continuous treatment of motor fluctuations (\u201con-off\u201d episodes) in PD; SPN-820 for treatment-resistant depression; and SPN-817 for the treatment of epilepsy.<\/p>\n<p>See full Prescribing Information for our products here: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wCGiZiUn4NyDhGyEo_v1yl7jrzIxE3tKCh3oBAdJpBEMmjBQyNJWCwUzxbDX_xkxwEwDEb4FaRWfZLl7TkiSFZi_9X0DxTMOo6sZbFYkuV9g6eAZ4thx0JjxnScW4gS7faxl6-EtxteNltppbK9R-U3anRDn5vahnM7RsRqxLHc=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Trokendi XR<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eZOGfNtzNooFwopK1CnZG5L5slrcmBteO-lJ8sgLgEyExh5JK8AX7Tm30WNxqQsNTfsdbyuuvM3xu4Cy_rWPZkIxdEyR-r0LToUrB8cyLdMcjAYAY1lt63rzoJxQcntfufsw8ald3hytZWai0fBlLkzmL_OfZhUFvfP4v2Xa82o=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Oxtellar XR<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8eLPHT_eKthYMDicE6BMKXBgSuZ1RG5Uf9cWtQE0N0nnoSvIl006rLqtdOvNzRMqGP0qtq-NKc_fKDjMDGdPD2038k7PDTxnmgGQQSupQewVg2R6fZmYXW6e0_yND0DeTQ65dcDUpPZzovJmCGRhCnOYu08LCX96UELsS_uuMc0=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">APOKYN<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ekjw2zgXK7o5Zf1XIMFpFfhxt_10XW_68y4XDeWxTxAjTI1G8zWDOBOtZ67Z10Iz6Kur9hDgAQiwQUl2eWybjREc1j4EFMCO2NJDYPstz6MygXBZV_v8glPMHkS5a86QqYT7U5pGlzyVNjrTcTeQuEBzMfqgZikCeVG2PXG7zfo=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">MYOBLOC<\/a>, and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=D1CSoRHVi2CpSOYo813IGeAlP-OwfAfnNmDK4D1Uvq6g2CBIR5d5LQcwDFlCAWzfqtvxJ6hxmlUYoWXbKB0c1lX9-zE6yfFwu7ShC-urOZxbzIHk4u0MrHSZrQoF_dEjbhvUv-m5B9r4_BwSHxIS6DDkuGckXzsQ6iUM2mTu__4=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">XADAGO<\/a>.<\/p>\n<p>All trademarks are the property of their respective owners.<\/p>\n<p>\n        <strong>CONTACTS:<\/strong><br \/>\n        <br \/>Jack A. Khattar, President and CEO<br \/>Jim Kelly, EVP &amp; Chief Financial Officer<br \/>Supernus Pharmaceuticals, Inc.<br \/>Tel: (301) 838-2591<\/p>\n<p>\n        <strong>or<\/strong>\n      <\/p>\n<p>\n        <strong>INVESTOR CONTACT:<\/strong><br \/>\n        <br \/>Peter Vozzo<br \/>Westwicke, an ICR Company<br \/>Office: (443) 213-0505<br \/>Mobile: (443) 377-4767<br \/>Email: peter.vozzo@westwicke.com<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTg0MCMzOTA3Njc5IzIwMTA5NDI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/d0dd954c-7ce3-47a8-b3a0-33992249a500\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ROCKVILLE, Md., Jan. 06, 2021 (GLOBE NEWSWIRE) &#8212; Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company&#8217;s management will present at the J.P. Morgan 39th Annual Healthcare Conference on Thursday, January 14, 2021, at 9:10 a.m. ET, and will be available for virtual investor meetings. A live webcast of the presentation can be accessed by visiting Events &amp; Presentations in the Investor Relations section on the Company&#8217;s website at www.supernus.com. An archived replay of this webcast will be available for 60 days on the Company&#8217;s website after the conference. About Supernus Pharmaceuticals,\u00a0Inc. Supernus Pharmaceuticals, Inc. is a pharmaceutical company focused on &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Supernus to Present at J.P. Morgan 39th Annual Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-409984","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Supernus to Present at J.P. Morgan 39th Annual Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Supernus to Present at J.P. Morgan 39th Annual Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ROCKVILLE, Md., Jan. 06, 2021 (GLOBE NEWSWIRE) &#8212; Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company&#8217;s management will present at the J.P. Morgan 39th Annual Healthcare Conference on Thursday, January 14, 2021, at 9:10 a.m. ET, and will be available for virtual investor meetings. A live webcast of the presentation can be accessed by visiting Events &amp; Presentations in the Investor Relations section on the Company&#8217;s website at www.supernus.com. An archived replay of this webcast will be available for 60 days on the Company&#8217;s website after the conference. About Supernus Pharmaceuticals,\u00a0Inc. Supernus Pharmaceuticals, Inc. is a pharmaceutical company focused on &hellip; Continue reading &quot;Supernus to Present at J.P. Morgan 39th Annual Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-06T22:32:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTg0MCMzOTA3Njc5IzIwMTA5NDI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Supernus to Present at J.P. Morgan 39th Annual Healthcare Conference\",\"datePublished\":\"2021-01-06T22:32:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\\\/\"},\"wordCount\":323,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTg0MCMzOTA3Njc5IzIwMTA5NDI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\\\/\",\"name\":\"Supernus to Present at J.P. Morgan 39th Annual Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTg0MCMzOTA3Njc5IzIwMTA5NDI=\",\"datePublished\":\"2021-01-06T22:32:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTg0MCMzOTA3Njc5IzIwMTA5NDI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTg0MCMzOTA3Njc5IzIwMTA5NDI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Supernus to Present at J.P. Morgan 39th Annual Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Supernus to Present at J.P. Morgan 39th Annual Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Supernus to Present at J.P. Morgan 39th Annual Healthcare Conference - Market Newsdesk","og_description":"ROCKVILLE, Md., Jan. 06, 2021 (GLOBE NEWSWIRE) &#8212; Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company&#8217;s management will present at the J.P. Morgan 39th Annual Healthcare Conference on Thursday, January 14, 2021, at 9:10 a.m. ET, and will be available for virtual investor meetings. A live webcast of the presentation can be accessed by visiting Events &amp; Presentations in the Investor Relations section on the Company&#8217;s website at www.supernus.com. An archived replay of this webcast will be available for 60 days on the Company&#8217;s website after the conference. About Supernus Pharmaceuticals,\u00a0Inc. Supernus Pharmaceuticals, Inc. is a pharmaceutical company focused on &hellip; Continue reading \"Supernus to Present at J.P. Morgan 39th Annual Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-06T22:32:24+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTg0MCMzOTA3Njc5IzIwMTA5NDI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Supernus to Present at J.P. Morgan 39th Annual Healthcare Conference","datePublished":"2021-01-06T22:32:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\/"},"wordCount":323,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTg0MCMzOTA3Njc5IzIwMTA5NDI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\/","name":"Supernus to Present at J.P. Morgan 39th Annual Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTg0MCMzOTA3Njc5IzIwMTA5NDI=","datePublished":"2021-01-06T22:32:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTg0MCMzOTA3Njc5IzIwMTA5NDI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTg0MCMzOTA3Njc5IzIwMTA5NDI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-to-present-at-j-p-morgan-39th-annual-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Supernus to Present at J.P. Morgan 39th Annual Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/409984","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=409984"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/409984\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=409984"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=409984"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=409984"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}